key: cord-0829100-kqu0cnew
authors: Petersen, Rune M.; Tornby, Ditte S.; Bistrup, Claus; Johansen, Isik S.; Andersen, Thomas E.; Justesen, Ulrik S.
title: Negative SARS-cov-2 antibodies, T-cell response and virus neutralisation following full vaccination in a renal transplant recipient – A call for vigilance
date: 2021-06-07
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2021.05.042
sha: bcc8cf097e4f1a723724c1704ca65edd10971985
doc_id: 829100
cord_uid: kqu0cnew

This letter concerns the absence of an immunological response in a renal transplant recipient on immunosuppressive therapy after a full vaccination against SARS-CoV-2 and the need to be vigilant. We find it very important to report this to the scientific community, so that transplant patients can be monitored, protected and helped to stimulate further immunity.

Coronavirus disease 2019 (COVID-19) have overwhelmed the world since the end of 2019. In recent 27 months, great optimism has been a result of an increasing number of available vaccines showing protection 28 rates up to 95% in preventing COVID-19 [1] . However, the vaccines have not been tested in a number of 29 frail patients, including organ transplant recipients. 30 31 We followed two completely stable patients on haemodialysis. Patient 1 was a 43 years old female, who 32 had been on haemodialysis for 2½ years. She was not a transplant recipient and did not receive 33 immunosuppressive therapy, but received levothyroxine, antihypertensive medication, phosphate binders, 34 darbepoitin alfa and vitamins. Complete blood cell counts were normal before vaccination. Creatinine was 35 613 µmol/L (reference: 45-90) and blood urea nitrogen 13.3 mmol/L (reference: 2.6-6.4). Patient 2 was a 58 36 years old male, who had been on haemodialysis for half a year and had three renal transplantations with 37 the latest in 2011. He received mycophenolic acid 360 mg plus tacrolimus 3 mg daily (not prednisolone). He 38 also received antihypertensive medication, phosphate binders, allopurinol, darbepoitin alfa and vitamines. 39

Complete blood cell counts were normal apart from a slightly elevated white blood cell count of 11.0 x 10 9 40 cells/L (reference: 3.5-8.8) because of crystal synovitis. The creatinine was 777 µmol/L (reference: 60-105) 41 and blood urea nitrogen 18.4 mmol/L (reference: 3.5-8.1). Both patients were followed from the start of The mixtures were placed onto a monolayer of Vero-E6 cells (ATCC® CRL-1586™) in 6-well microtiter plates 63 and incubated for another hour. Overlay medium with 1% agarose was added and the plates were 64 incubated for three days. After fixation and staining, plaques were counted. The highest plasma dilution 65 enabling a >90% plaque reduction was defined as the titer. Titers >1:10 were defined as neutralising [5] . 66

The SARS-CoV-2 antibody response is shown in Fig. 1 . 

Online ahead of print

Clinical evaluation of 129 four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 130 infection

A whole blood test to 133 measure SARS-CoV-2-specific response in COVID-19 patients

Serological assays for severe acute 137 respiratory syndrome coronavirus 2 (SARS-CoV-2)

Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients